Visual improvement during octreotide therapy in a case of episellar meningioma

Clinical Neurology and Neurosurgery

Volumn 100, Issue 1, 1998, Pages 40-43

  Jaffrain Rea, Marie Lise ^a   Minniti, Giuseppe ^b   Santoro, Antonio ^b   Bastianello, Stefano ^b   Tamburrano, Guido ^b   Gulino, Alberto ^a   Cantore, Giampaolo ^b  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Meningioma; Octreotide; Optic nerve; Pituitary neoplasm

Indexed keywords

HYPOTHALAMUS RELEASE INHIBITING FACTOR; OCTREOTIDE;

ADULT; ARTICLE; CASE REPORT; COMPRESSION; FEMALE; HUMAN; HYPOPHYSIS ADENOMA; MENINGIOMA; OPTIC TRACT; SELLA TURCICA; SUBCUTANEOUS DRUG ADMINISTRATION; VISUAL FIELD DEFECT;

ADENOMA; ANTINEOPLASTIC AGENTS, HORMONAL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; OCTREOTIDE; PITUITARY NEOPLASMS; TREATMENT OUTCOME; VISION DISORDERS;

EID: 0031834707     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-8467(97)00110-8     Document Type: Article

References (17)

1. Michael A.S., Page M.L. MR imaging of intrasellar meningiomas simulating pituitary adenomas. J. Comput. Assist. Tomogr. 12:1988;944-946.
2. Taylor S.L., Barakos J.A., Harsh G.R., Wilson C.B. Magnetic resonance imaging of the tuberculum sellae meningiomas: preventing preoperative misdiagnosis as pituitary macroadenoma. Neurosurgery. 31:1992;621-627.
3. Stevenaert A., Harris A.G., Kovacs K., Beckers A. Presurgical octreotide treatment in acromegaly. Metabolism. 41:1992;51-58.
4. Warnet A., Timsit J., Chanson P., Guillausseau P.J., Zamfirescu F., Harris A., Derome P., Cophignon J., Lubetzki J. The effect of SMS analogue on chiasmal dysfunction from pituitary macroadenomas. J. Neurosurg. 71:1989;687-691.
5. De Bruin T.W., Kwekkeboom D.J., Van't Verlaat J.W., Reubi J.C., Krenning E.P., Lamberts S.W.J., Croughs R.J.M. Clinically non-functioning pituitary adenoma and octreotide response to long-term high dose treatment, and studies in vitro. J. Clin. Endocrinol. Metab. 75:1992;1310-1317.
6. Runzi M.W., Jaspers C., Windeck R., Benker G., Mehdorn H.M., Reinhart V., Reinwein D. Successful treatment of meningioma with octreotide. Lancet. May 13 (Letter):1989;1074.
7. Lamberts S.W.J. The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors. Endocrinol. Rev. 9:1988;417-436.
8. 111Indium (DTPA-octreotide)-scintigraphy in meningioma patients. Acta Neurochir. (Wien). 126:1994;63-71.
9. Reubi J.C., Maurer R., Klijn J.G.M., Stefanko S.Z., Foekens J.A., Blaauw G., Blankenstein M.A., Lamberts S.W.J. High incidence of somatostatin receptors in human meningiomas: biochemical characterization. J. Clin. Endocrinol. Metab. 63:1986;433-438.
10. Kunert-Radek J., Stepien H., Radek A., Pawlikowski M. SMS suppression of meningioma cell proliferation in vitro. Acta Neurol. Scand. 75:1987;434-436.
11. Glick R.P., Gettleman R., Lakshman R., Tsibris J.C. Insulin and insulin-like growth factor I in brain tumors: binding and in vitro effects. Neurosurgery. 24:1989;797-797.
12. Antoniades H.N., Galanopoulos T., Neville-Golden J., Maxwell M. Expression of insuline-like growth factors I and II and their receptors mRNA in primary human astrocytomas and meningiomas; in vivo studies using in situ hybridization and immunocytochemistry. Int. J. Cancer. 50:1992;215-222.
13. Hierowski M.T., Liebow C., Du Sapin K., Schally A.V. Stimulation by somatostatin of dephosphorylation of membrane proteins in pancreatic cancer MIA PaCa-2 cell line. FEBS Lett. 179:1985;252-256.
14. Garcia-Luna P.P., Relimpio F., Pumar A., Pereira J.L., Leal-Cerro A., Trujillo F., Cortes A., Astorga R. Clinical use of octreotide in unresectable meningiomas. A report of three cases. J. Neurosurg. Sci. 37:1993;237-241.
15. Lamberts S.W.J., Van Der Lely A.J., De Herder W.W., Hofland L.J. Drug therapy: octreotide. New Engl. J. Med. 4:1996;246-254.
16. Philippon J., Foncin J.F., Grob R., Srour A., Poisson M., Pertuiset B.F. Cerebral edema associated with meningiomas: possible role of a secretory-excretory phenomenon. Neurosurgery. 14:1984;295-301.
17. Ducati A., Losa M., Fava E., Cenzato M., Giovanelli M. Acute effects on visual function of a Somatostatin analog (SMS 201-995) evaluated using a neurophysiological approach. J. Endocrinol. Invest. 14(Suppl 1, Abstract P144):1991;120.